Corrigendum to “Down-Regulation of HSP27 Sensitizes TRAIL-resistant Tumor Cell to TRAIL-induced Apoptosis” [lung Cancer 68 (1) (2010) 27–38]

Hongqin Zhuang,Weiwei Jiang,Wei Cheng,Kui Qian,Wei Dong,Lin Cao,Qilai Huang,Shufeng Li,Fei Dou,Jen-Fu Chiu,Xue-Xun Fang,Min Lu,Zi-Chun Hua

DOI: https://doi.org/10.1016/j.lungcan.2020.01.003

IF: 6.081

2020-01-01

Lung Cancer

Abstract:The authors regret that there is a mistake in the original manuscript in the text mark of Fig. 8D, in which P53 should be marked as phospho-P53. Now we would like to provide a new Fig. 8D as follows. In addition, on Page 35 section 3.4.4, Effect on p53, the paper should be read as follows: p53 protein is one of the most important tumor suppressor genes. It exerts a general antiproliferative effect by inducing cell cycle arrest or apoptosis. Western blot analysis showed that TRAIL combined with HSP27 siRNA treatment markedly increased the protein level of phopspho-p53 in A549 cells compared to treatment with TRAIL or HSP27 siRNA alone or TRAIL plus control siRNA (Fig. 8D). The authors would like to apologise for any inconvenience caused. Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosisLung CancerVol. 68Issue 1PreviewTumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) has recently emerged as a cancer therapeutic agent because it preferentially induces apoptosis in human cancer over normal cells. Most tumor cells, including lung cancer cell line A549, unfortunately, are resistant to TRAIL treatment even at high dose. Recent studies indicated that TRAIL-resistant cancer cells could be sensitized to TRAIL by combination therapy. Stress and heat shock proteins such as HSP90, HSP70 and HSP27 are induced in response to a wide variety of physiological environmental insults including heat, reactive oxygen species or anticancer drugs. Full-Text PDF